| Lactose (India) Ltd | 127 Cr. | 101 | 185/84.3 | 28.1 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,684 Cr. | 338 | 479/192 | 77.1 | 24.3 | 0.20 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 31.4 Cr. | 42.2 | 82.0/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 79.8 Cr. | 54.5 | 54.5/17.0 | 190 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 67.3 Cr. | 89.4 | 115/69.7 | 18.2 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,233 Cr. | 1,958 | 2,286/1,275 | 20.4 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 305 Cr. | 12.6 | 17.2/10.8 | 18.3 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 957 Cr. | 1,783 | 1,999/635 | 28.1 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 96.2 Cr. | 19.2 | 29.8/17.0 | 27.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 913 Cr. | 310 | 449/219 | 10.3 | 133 | 0.81 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.75 Cr. | 13.1 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.77 Cr. | 3.12 | 8.28/2.11 | 4.41 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 408 Cr. | 420 | 536/211 | 61.6 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 5,012 Cr. | 1,152 | 1,511/944 | 45.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 49.1 Cr. | 0.24 | 1.12/0.20 | 3.23 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 32.6 Cr. | 12.4 | 26.3/11.2 | 15.9 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 8.24 Cr. | 8.16 | 14.8/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 171 Cr. | 478 | 851/415 | 9.67 | 596 | 0.31 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 80.5 Cr. | 80.5 | 92.5/26.1 | 152 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 13,464 Cr. | 1,282 | 2,280/1,100 | 41.9 | 174 | 0.83 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 7.22 Cr. | 57.3 | 88.7/36.1 | 14.7 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.9 Cr. | 113 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 55.5 Cr. | 102 | 144/12.2 | 27.0 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.8 Cr. | 42.2 | 73.0/33.0 | 51.4 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.72 Cr. | 19.0 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,681 Cr. | 442 | 1,028/392 | 21.8 | 72.4 | 0.27 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 81.8 Cr. | 18.9 | 28.8/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.0 Cr. | 21.7 | 34.2/17.4 | 1,100 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 85,544 Cr. | 2,073 | 2,727/2,029 | 48.4 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 230 Cr. | 400 | 524/241 | 23.6 | 123 | 1.12 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 60.3 Cr. | 42.0 | 47.9/26.7 | 94.2 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 65,421 Cr. | 1,124 | 1,279/994 | 18.5 | 603 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 176 Cr. | 282 | 303/159 | 59.6 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 841 Cr. | 84.0 | 115/68.0 | 20.1 | 32.6 | 1.79 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 33.3 Cr. | 25.5 | 40.5/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 16,798 Cr. | 2,050 | 2,120/930 | 58.5 | 173 | 0.07 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 5.28 Cr. | 0.80 | 1.06/0.51 | 75.5 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 200 Cr. | 26.2 | 52.0/23.1 | 12.8 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.22 Cr. | 14.0 | 19.1/7.60 | 274 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 122 Cr. | 5.18 | 6.57/2.82 | | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,005 Cr. | 27,295 | 37,000/26,430 | 38.4 | 1,888 | 1.74 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,919 Cr. | 764 | 972/557 | 32.0 | 226 | 0.65 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 185 Cr. | 65.3 | 100/31.3 | 51.6 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,690 Cr. | 1,389 | 1,740/752 | | 93.5 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,186 Cr. | 1,429 | 1,870/1,110 | 213 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 914 Cr. | 261 | 330/154 | 21.3 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 59.2 Cr. | 7.15 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 991 Cr. | 745 | 873/278 | 13.0 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,698 Cr. | 386 | 730/361 | 25.6 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,354 Cr. | 947 | 1,402/935 | 19.4 | 768 | 1.06 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,38,127 Cr. | 4,080 | 4,125/2,886 | 63.8 | 250 | 0.78 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 836 Cr. | 91.1 | 220/75.2 | | 41.3 | 0.55 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,350 Cr. | 14.4 | 23.5/11.5 | 21.5 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 13,549 Cr. | 354 | 1,328/334 | 39.4 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,669 Cr. | 158 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,09,758 Cr. | 1,708 | 1,851/1,547 | 33.8 | 324 | 0.94 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,166 Cr. | 490 | 734/440 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,984 Cr. | 318 | 360/175 | 34.2 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,642 Cr. | 340 | 502/260 | 37.5 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,419 Cr. | 4,093 | 6,718/3,976 | 25.5 | 340 | 2.86 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,456 Cr. | 2,072 | 2,725/1,772 | 32.9 | 335 | 0.97 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,131 Cr. | 5,498 | 6,739/4,904 | 31.1 | 373 | 2.27 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 138 Cr. | 39.2 | 76.0/37.1 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,711 Cr. | 4,961 | 5,993/3,701 | 29.8 | 841 | 0.71 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 119 Cr. | 96.7 | 182/81.0 | 12.3 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,295 Cr. | 374 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,496 Cr. | 689 | 1,327/604 | 66.9 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 17,273 Cr. | 13,502 | 19,748/10,060 | 96.4 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 266 Cr. | 13.7 | 35.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,179 Cr. | 847 | 1,280/660 | 9.86 | 483 | 0.71 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,186 Cr. | 39.9 | 70.5/33.5 | 28.6 | 21.8 | 0.50 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,471 Cr. | 187 | 271/156 | 23.5 | 59.3 | 0.43 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 52.9 Cr. | 33.3 | 116/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 261 Cr. | 72.9 | 136/67.8 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,00,622 Cr. | 2,204 | 2,249/1,774 | 23.3 | 430 | 0.54 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,071 Cr. | 535 | 710/440 | 13.4 | 357 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 52,137 Cr. | 966 | 1,141/512 | 65.1 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,180 Cr. | 1,137 | 1,235/596 | 24.0 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 122 Cr. | 57.0 | 114/51.0 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 691 Cr. | 143 | 215/120 | 41.8 | 104 | 2.10 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 645 Cr. | 369 | 500/265 | 23.4 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 14,912 Cr. | 936 | 1,250/802 | 32.3 | 414 | 0.53 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 30,850 Cr. | 1,923 | 1,939/1,303 | 40.9 | 243 | 0.81 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,229 Cr. | 185 | 302/155 | 28.9 | 37.9 | 1.35 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,191 Cr. | 1,426 | 1,595/1,168 | 36.6 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,364 Cr. | 81.0 | 127/57.5 | 20.4 | 59.7 | 0.99 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,116 Cr. | 137 | 143/67.2 | 23.6 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,945 Cr. | 210 | 350/190 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,321 Cr. | 189 | 457/177 | 230 | 96.9 | 0.74 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,323 Cr. | 1,547 | 2,350/1,243 | 32.3 | 397 | 0.45 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,190 Cr. | 317 | 420/285 | 58.7 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,103 Cr. | 581 | 627/412 | 26.0 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 55,233 Cr. | 1,958 | 2,286/1,275 | 20.4 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 44,526 Cr. | 2,623 | 3,516/1,968 | 44.3 | 101 | 1.60 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,060 Cr. | 1,886 | 2,131/1,200 | 26.2 | 610 | 0.95 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,451 Cr. | 397 | 528/357 | 27.8 | 149 | 1.26 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,308 Cr. | 1,465 | 1,910/1,097 | 48.8 | 227 | 0.50 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,879 Cr. | 1,256 | 1,380/1,020 | 18.8 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,285 Cr. | 210 | 322/178 | 24.9 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,08,416 Cr. | 1,342 | 1,673/1,282 | 22.8 | 408 | 0.97 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,149 Cr. | 1,732 | 2,397/1,551 | 21.4 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 216 Cr. | 74.2 | 166/58.4 | 10.0 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,200 Cr. | 208 | 215/105 | 19.9 | 107 | 0.24 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 61.5 Cr. | 37.4 | 58.0/28.5 | 21.6 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 60,152 Cr. | 371 | 425/291 | 127 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,381 Cr. | 1,368 | 2,000/1,354 | 30.5 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 111 Cr. | 70.1 | 129/64.0 | 16.3 | 49.2 | 1.71 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 300 Cr. | 128 | 205/67.8 | 28.4 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,396 Cr. | 8,960 | 10,691/6,502 | 96.9 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,846 Cr. | 638 | 791/544 | 31.9 | 118 | 0.72 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 155 Cr. | 74.2 | 125/61.0 | 8.22 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 69,532 Cr. | 5,812 | 5,934/4,492 | 29.6 | 1,116 | 0.77 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,761 Cr. | 802 | 1,108/725 | 23.8 | 271 | 1.37 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 402 Cr. | 707 | 1,184/663 | | 690 | 0.71 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 36,164 Cr. | 2,891 | 3,021/2,022 | 35.6 | 345 | 0.97 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,352 Cr. | 299 | 367/258 | 23.3 | 133 | 1.74 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,468 Cr. | 380 | 575/312 | 18.7 | 147 | 0.53 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,100.96 Cr | 1,117.30 | | 54.75 | 201.93 | 0.36% | 16.29% | 15.20% | 6.10 |